Covid-19 roundup: Eli Lil­ly with­draws mAbs from EMA re­view

The World Health Or­ga­ni­za­tion has grant­ed In­di­an-pro­duced Covid-19 vac­cine emer­gency use list­ing, adding to its port­fo­lio of ac­cept­able vac­cines.

A ad­vi­so­ry group de­ter­mined that Co­v­ax­in, pro­duced by In­di­an drug­mak­er Bharat Biotech, meets WHO stan­dards, and that the ben­e­fits of the vac­cine far out­weighs the risks. Two dos­es, ad­min­is­tered with four weeks time in be­tween, are rec­om­mend­ed in all age groups above 18, though vac­cine safe­ty and ef­fi­ca­cy was not de­ter­mined for preg­nant women just yet, the WHO tweet­ed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER